What Merieux Foundation does

Fondation Mérieux is a French non-profit foundation recognized as a public utility since 1976 and headquartered in Lyon, France, dedicated to combating infectious diseases in resource-limited countries. Founded in 1967 by Alain Mérieux, the foundation operates across four priority areas — antimicrobial resistance, tuberculosis, acute respiratory infections, and emerging pathogens — through an integrated model combining laboratory network development, applied operational research, and knowledge sharing. Its core assets include the GABRIEL research network (22 member laboratories in 16 countries), the RESAOLAB West African laboratory network, and a portfolio of flagship training programs (ACDx, Afro-ACDx, ADVAC, AMR One Health course, Epidemiology in Complex Emergencies, and a MOOC on quality management), alongside disease-specific operational research projects such as APRECIT for latent tuberculosis screening in Cameroon and Madagascar.

The foundation delivers impact through 16 local teams spanning 25 countries in Africa, the Middle East, and Asia, supported by 14 regional offices, the Les Pensières Center for Global Health conference venue in Veyrier-du-Lac, France, and a wholly-owned US subsidiary (Fondation Mérieux USA). Its revenue model is a hybrid of foundation grants and endowments (Expertise France / L'Initiative, bioMérieux, Sanofi, Takeda, Global Fund, Gavi), tiered training-course registration fees ranging from roughly €1,500 to €4,800 depending on participant category, and subsidized fellowships for low- and middle-income country participants. Governance is anchored by strategic alliances with WHO, UNICEF, US CDC, Africa CDC, FIND, CHAI, Institut Pasteur, University of Geneva, LSHTM, and the Institut de Recherche pour le Développement, embedding the foundation in the global laboratory-strengthening architecture.

Go-to-market is event-driven and community-led: conferences, residential courses, webinars, GABRIEL network meetings every 18 months, and field projects coordinated with ministries of health and national reference laboratories. While there is no commercial product, the foundation functions as a quasi-platform that convenes funders, researchers, and public-health practitioners, with Mérieux family governance and close (but operationally independent) ties to bioMérieux providing reputational and intellectual continuity.

Name

Merieux Foundation

Legal name

Fondation Mérieux

Website

https://fondation-merieux.org

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

51–100 employees

Short description

Fondation Mérieux is a French public-utility foundation, founded in 1967, that combats infectious diseases in resource-limited countries by building laboratory capacity, running the GABRIEL research network across 22 labs in 16 countries, and delivering flagship training courses for global health professionals across 25 countries in Africa, the Middle East, and Asia.

Ownership category

akta.pro rank

Product category

Global Public Health & Infectious Disease Foundation Services

NAICS

Scientific Research and Development Services (5417), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Health Services (8000)

akta.pro primary industry

Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH)

akta.pro secondary industries

Health Systems Strengthening & Primary Care Development (HLAJAKAJ), Monitoring, Evaluation, Research & Learning (MERL) (BPAGABAO)

Keywords

• Infectious disease diagnostics
• Public health capacity building
• Laboratory network development
• Global health training
• Antimicrobial resistance surveillance

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices14 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Foundation Funding and Grants: The foundation operates as a non-profit recognized as a public utility (fondation reconnue d'utilité publique), funded through endowments, donations, and partnerships with financial backers including governments, international organizations, and private donors.
2. Training Course Fees: Revenue generated from registration and accommodation fees for advanced training courses (ACDx, Afro-ACDx, ADVAC, AMR courses, epidemiology courses). Fee structures vary by participant category (academic/government, industry, sponsors).
3. Project Grants and Sponsorships: Funding from institutional partners such as Expertise France/L'Initiative, government agencies, and international organizations for specific research and public health projects.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Fondation Mérieux is an independent non-profit foundation that fights infectious diseases in resource-limited countries by improving diagnostic and surveillance capabilities of local health systems, conducting applied research, and delivering knowledge-sharing/training programs. It operates 14 regional offices, runs the GABRIEL research network (22 labs in 16 countries), and offers advanced training courses (ACDx, Afro-ACDx, ADVAC, AMR, epidemiology) for laboratory professionals and global health decision-makers.

Product overview

The Merieux Foundation is a non-profit foundation recognized as a public utility since 1967, dedicated to fighting infectious diseases in resource-limited countries. Its mission focuses on four key objectives: improving diagnosis and surveillance, promoting applied research and innovation, developing knowledge sharing, and adopting an integrated global health approach. The Foundation operates across 25 countries with 16 local teams managing over 100 projects annually. Its offerings include training programs (ACDx, Afro-ACDx, ADVAC, AMR Course, Epidemiology Course, MOOC on Quality Management), research networks (GABRIEL network with 22 laboratories in 16 countries), and specific projects like APRECIT focused on tuberculosis in Cameroon and Madagascar.

Differentiator

Problem solved

Functional benefit

Brands

• Les Pensières Center for Global Health: Conference center in Veyrier-du-Lac, France, where the foundation hosts training courses and events
• RESAOLAB
• GABRIEL Network

Products and services

• Advanced Course on Diagnostics (ACDx) Intensive week-long training course promoting the role and value of medical diagnostics in global health, building capacity for critical decision-making in developing countries; co-led with London School of Hygiene & Tropical Medicine.

Quantifiable outcome

• 5,000+ healthcare professionals trained through courses annually
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

22 partnerships are on record, tiered core and secondary.

• Institut de Recherche pour le Développement (IRD)coreStrategic or Co-development PartnerPartnership renewed in April 2026 for reinforced cooperation in global public health. Collaboration focuses on research and capacity building in developing countries.
• Institut Pasteur of DakarcoreStrategic or Co-development PartnerCo-organizes the Afro-ACDx (Advanced Course on Diagnostics in French) annually in Senegal since 2021. The course brings together French-speaking African laboratory professionals.
• London School of Hygiene & Tropical Medicine (LSHTM)coreStrategic or Co-development PartnerCo-leads the ACDx (Advanced Course on Diagnostics) with LSHTM since 2023. Steering committee member for course development.
• University of GenevacoreStrategic or Co-development PartnerCo-organizes the ADVAC (Advanced Course of Vaccinology) annually. The course brings together 75-80 international participants and over 80 world-renowned speakers.
• Université Paris CitécoreStrategic or Co-development PartnerCo-designs the Antimicrobial Resistance (AMR) One Health course addressing the five objectives of the WHO AMR Global Action Plan. Targets professionals from low- and middle-income countries.
• EpiconceptsecondaryStrategic or Co-development PartnerCo-organizes the Advanced course on epidemiology in complex emergencies, training French-speaking epidemiologists in One Health approaches to outbreak response.
• Every Breath Counts CoalitionsecondaryStrategic or Co-development PartnerCo-organized the workshop on PCV and Rotavirus vaccine introduction in Chad, Guinea, Somalia, and South Sudan, working with health ministries to save children's lives.
• Save the ChildrensecondaryStrategic or Co-development PartnerPartner in workshop on PCV and Rotavirus vaccine introduction in Chad, Guinea, Somalia, and South Sudan.
• Malaria ConsortiumsecondaryStrategic or Co-development PartnerCo-organized workshop supporting vaccine introduction in Chad, Guinea, Somalia, and South Sudan.
• International Vaccine Access Center (IVAC)secondaryStrategic or Co-development PartnerPartner providing evidence and support for PCV and Rotavirus vaccine introduction in four African countries.
• AfnorsecondaryStrategic or Co-development PartnerPartner in developing the MOOC on Quality Management in medical biology laboratories, providing expertise on ISO 15189 standard.
• Institut Pasteur (Network)coreStrategic or Co-development PartnerNetwork partner in developing the MOOC and various research collaborations. Multiple Institut Pasteur branches (Paris, Dakar, Madagascar) collaborate with the foundation.
• UNICEFcoreStrategic or Co-development PartnerSteering committee member for ACDx course; partner in global health initiatives including vaccine introduction workshops.
• World Health Organization (WHO)coreStrategic or Co-development PartnerSteering committee member for ACDx and Afro-ACDx courses; partner in AMR surveillance, TB programs, and outbreak response under One Health approach.
• US Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerSteering committee member for ACDx course; partner in GABRIEL network and global health security initiatives.
• Africa CDCcoreStrategic or Co-development PartnerSteering committee member for ACDx and Afro-ACDx courses; partner in continental disease surveillance and laboratory strengthening.
• Clinton Health Access Initiative (CHAI)secondaryStrategic or Co-development PartnerSteering committee member for ACDx course; partner in expanding access to diagnostics and health technologies.
• Foundation for Innovative New Diagnostics (FIND)coreStrategic or Co-development PartnerSteering committee member for ACDx and Afro-ACDx courses; partner in diagnostics development and evaluation.
• Hospices Civils de LyonsecondaryStrategic or Co-development PartnerScientific committee member for epidemiology in complex emergencies course.
• West African Health Organization (WAHO)coreStrategic or Co-development PartnerScientific committee member for epidemiology and Afro-ACDx courses; partner in West African health initiatives.
• Centre Pasteur du CamerouncoreStrategic or Co-development PartnerPartner laboratory in APRECIT project for latent TB research in Cameroon.
• Institut Pasteur de MadagascarcoreStrategic or Co-development PartnerResearch partner in APRECIT project and GABRIEL network, conducting TB and infectious disease research.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PATH: PATH is a global health nonprofit focused on vaccines, diagnostics, and infectious diseases in developing countries, with applied research and country implementation programs that closely mirror Mérieux's mix of lab strengthening, training, and product introduction.
• Foundation for Innovative New Diagnostics (FIND): FIND is a direct ACDx/Afro-ACDx steering-committee partner that develops and evaluates diagnostics for poverty-related diseases, sharing Mérieux's focus on TB, AMR, and emerging pathogens in LMIC laboratory networks.
• Institut Pasteur: Institut Pasteur is a longstanding research and network collaborator (Paris, Dakar, Madagascar, Cameroun) working on infectious diseases, reference laboratories, and training — operating an overlapping international laboratory network similar to Mérieux's GABRIEL and RESAOLAB.
• Clinton Health Access Initiative (CHAI): CHAI is a direct partner of Fondation Mérieux on the ACDx steering committee and works on diagnostics access, pricing, and lab capacity in LMICs — closely overlapping with Mérieux's mission of expanding diagnostic capability in resource-limited countries.
• African Field Epidemiology Network (AFENET): AFENET trains field epidemiologists and strengthens laboratory capacity across African Union member states, directly comparable to Mérieux's training-course, RESAOLAB, and applied-epidemiology footprint in the same geographies.
• Médecins Sans Frontières (MSF): MSF operates infectious-disease programs in many of the same fragile LMIC geographies (including Sahel, Lebanon, Myanmar) and runs its own reference laboratory capacity; while more delivery-focused than Mérieux, it shares the mission of combatting infectious diseases in resource-limited and conflict-affected settings.

Broad incumbents

• The Global Fund to Fight AIDS, Tuberculosis and Malaria: The Global Fund is an ACDx steering-committee partner and the dominant financier of TB, HIV, and malaria laboratory systems in Mérieux's operating countries; it shares the laboratory-strengthening agenda but at incomparably larger scale.
• Gavi, the Vaccine Alliance: Gavi is a much larger global-health financing mechanism for vaccine introduction and an active Mérieux partner (PCV/Rotavirus introduction in Chad, Guinea, Somalia, South Sudan); it operates across the same LMIC vaccine space but at a vastly greater balance-sheet scale.
• Bill & Melinda Gates Foundation: The Gates Foundation is the largest global-health philanthropy with deep portfolios in vaccines, diagnostics, and infectious diseases; it competes for the same donor mindshare and LMIC ministry relationships that Mérieux cultivates, but at multi-billion-dollar scale.
• Wellcome Trust: Wellcome Trust is a major UK-based infectious-disease research and AMR funder that overlaps with Mérieux's One Health and AMR agenda; as a far larger generalist philanthropy, it sits in the same donor and policy circles but with a much broader mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MerieuxFdn
• Facebookfacebook.com/merieuxfoundation

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Merieux Foundation